Selection of a mobilization regimen for multiple myeloma based on the response to induction therapy: Granulocyte-colony stimulating factor (G-CSF) alone versus high-dose cyclophosphamide plus G-CSF

Ji Eun Jang, June Won Cheong, Soo Jeong Kim, Hyunsoo Cho, Cheolwon Suh, Hyewon Lee, Hyeon Seok Eom, Ho Young Yhim, Won Sik Lee, Chang Ki Min, Jae Hoon Lee, Joon Seong Park, Jinseok Kim

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

To evaluate the feasibility of selecting a mobilization regimen based on the response to induction therapy, we retrospectively analyzed 179 multiple myeloma patients who underwent stem cell mobilization. In comparison with patients who achieved at least a very good partial response (VGPR) to induction therapy and received granulocyte-colony stimulating factor (G-CSF) alone and patients who did not achieve a VGPR and received cyclophosphamide (CY) + G-CSF, treatment-related toxicity was greater and neutrophil engraftment was slower in the CY than the G-CSF group. The rate of requisite mobilization (≥ 2.0 × 10 6 /kg) was similar in both groups. Overall and progression-free survival was not different between patients in the G-CSF group and patients who achieved at least VGPR and received CY + G-CSF. In conclusion, response-adapted selection of a mobilization regimen is appropriate. G-CSF alone should be the preferred treatment for patients who achieved at least a VGPR to induction therapy.

Original languageEnglish
Pages (from-to)1389-1397
Number of pages9
JournalLeukemia and Lymphoma
Volume57
Issue number6
DOIs
Publication statusPublished - 2016 Jun 2

Fingerprint

Granulocyte Colony-Stimulating Factor
Multiple Myeloma
Cyclophosphamide
Therapeutics
Hematopoietic Stem Cell Mobilization
Disease-Free Survival
Neutrophils

All Science Journal Classification (ASJC) codes

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Jang, Ji Eun ; Cheong, June Won ; Kim, Soo Jeong ; Cho, Hyunsoo ; Suh, Cheolwon ; Lee, Hyewon ; Eom, Hyeon Seok ; Yhim, Ho Young ; Lee, Won Sik ; Min, Chang Ki ; Lee, Jae Hoon ; Park, Joon Seong ; Kim, Jinseok. / Selection of a mobilization regimen for multiple myeloma based on the response to induction therapy : Granulocyte-colony stimulating factor (G-CSF) alone versus high-dose cyclophosphamide plus G-CSF. In: Leukemia and Lymphoma. 2016 ; Vol. 57, No. 6. pp. 1389-1397.
@article{a1f0f5d218814a1daa51feb9f5675d09,
title = "Selection of a mobilization regimen for multiple myeloma based on the response to induction therapy: Granulocyte-colony stimulating factor (G-CSF) alone versus high-dose cyclophosphamide plus G-CSF",
abstract = "To evaluate the feasibility of selecting a mobilization regimen based on the response to induction therapy, we retrospectively analyzed 179 multiple myeloma patients who underwent stem cell mobilization. In comparison with patients who achieved at least a very good partial response (VGPR) to induction therapy and received granulocyte-colony stimulating factor (G-CSF) alone and patients who did not achieve a VGPR and received cyclophosphamide (CY) + G-CSF, treatment-related toxicity was greater and neutrophil engraftment was slower in the CY than the G-CSF group. The rate of requisite mobilization (≥ 2.0 × 10 6 /kg) was similar in both groups. Overall and progression-free survival was not different between patients in the G-CSF group and patients who achieved at least VGPR and received CY + G-CSF. In conclusion, response-adapted selection of a mobilization regimen is appropriate. G-CSF alone should be the preferred treatment for patients who achieved at least a VGPR to induction therapy.",
author = "Jang, {Ji Eun} and Cheong, {June Won} and Kim, {Soo Jeong} and Hyunsoo Cho and Cheolwon Suh and Hyewon Lee and Eom, {Hyeon Seok} and Yhim, {Ho Young} and Lee, {Won Sik} and Min, {Chang Ki} and Lee, {Jae Hoon} and Park, {Joon Seong} and Jinseok Kim",
year = "2016",
month = "6",
day = "2",
doi = "10.3109/10428194.2015.1102240",
language = "English",
volume = "57",
pages = "1389--1397",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Informa Healthcare",
number = "6",

}

Selection of a mobilization regimen for multiple myeloma based on the response to induction therapy : Granulocyte-colony stimulating factor (G-CSF) alone versus high-dose cyclophosphamide plus G-CSF. / Jang, Ji Eun; Cheong, June Won; Kim, Soo Jeong; Cho, Hyunsoo; Suh, Cheolwon; Lee, Hyewon; Eom, Hyeon Seok; Yhim, Ho Young; Lee, Won Sik; Min, Chang Ki; Lee, Jae Hoon; Park, Joon Seong; Kim, Jinseok.

In: Leukemia and Lymphoma, Vol. 57, No. 6, 02.06.2016, p. 1389-1397.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Selection of a mobilization regimen for multiple myeloma based on the response to induction therapy

T2 - Granulocyte-colony stimulating factor (G-CSF) alone versus high-dose cyclophosphamide plus G-CSF

AU - Jang, Ji Eun

AU - Cheong, June Won

AU - Kim, Soo Jeong

AU - Cho, Hyunsoo

AU - Suh, Cheolwon

AU - Lee, Hyewon

AU - Eom, Hyeon Seok

AU - Yhim, Ho Young

AU - Lee, Won Sik

AU - Min, Chang Ki

AU - Lee, Jae Hoon

AU - Park, Joon Seong

AU - Kim, Jinseok

PY - 2016/6/2

Y1 - 2016/6/2

N2 - To evaluate the feasibility of selecting a mobilization regimen based on the response to induction therapy, we retrospectively analyzed 179 multiple myeloma patients who underwent stem cell mobilization. In comparison with patients who achieved at least a very good partial response (VGPR) to induction therapy and received granulocyte-colony stimulating factor (G-CSF) alone and patients who did not achieve a VGPR and received cyclophosphamide (CY) + G-CSF, treatment-related toxicity was greater and neutrophil engraftment was slower in the CY than the G-CSF group. The rate of requisite mobilization (≥ 2.0 × 10 6 /kg) was similar in both groups. Overall and progression-free survival was not different between patients in the G-CSF group and patients who achieved at least VGPR and received CY + G-CSF. In conclusion, response-adapted selection of a mobilization regimen is appropriate. G-CSF alone should be the preferred treatment for patients who achieved at least a VGPR to induction therapy.

AB - To evaluate the feasibility of selecting a mobilization regimen based on the response to induction therapy, we retrospectively analyzed 179 multiple myeloma patients who underwent stem cell mobilization. In comparison with patients who achieved at least a very good partial response (VGPR) to induction therapy and received granulocyte-colony stimulating factor (G-CSF) alone and patients who did not achieve a VGPR and received cyclophosphamide (CY) + G-CSF, treatment-related toxicity was greater and neutrophil engraftment was slower in the CY than the G-CSF group. The rate of requisite mobilization (≥ 2.0 × 10 6 /kg) was similar in both groups. Overall and progression-free survival was not different between patients in the G-CSF group and patients who achieved at least VGPR and received CY + G-CSF. In conclusion, response-adapted selection of a mobilization regimen is appropriate. G-CSF alone should be the preferred treatment for patients who achieved at least a VGPR to induction therapy.

UR - http://www.scopus.com/inward/record.url?scp=84946962401&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84946962401&partnerID=8YFLogxK

U2 - 10.3109/10428194.2015.1102240

DO - 10.3109/10428194.2015.1102240

M3 - Article

C2 - 26428939

AN - SCOPUS:84946962401

VL - 57

SP - 1389

EP - 1397

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

SN - 1042-8194

IS - 6

ER -